Compare ADM & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADM | TEVA |
|---|---|---|
| Founded | 1902 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4B | 30.2B |
| IPO Year | N/A | N/A |
| Metric | ADM | TEVA |
|---|---|---|
| Price | $58.13 | $28.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $56.83 | $27.88 |
| AVG Volume (30 Days) | 3.0M | ★ 11.1M |
| Earning Date | 11-04-2025 | 01-28-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.46 | 0.62 |
| Revenue | ★ $83,211,000,000.00 | $16,776,000,000.00 |
| Revenue This Year | N/A | $4.74 |
| Revenue Next Year | $2.85 | $0.48 |
| P/E Ratio | ★ $23.54 | $46.12 |
| Revenue Growth | N/A | ★ 0.02 |
| 52 Week Low | $40.98 | $12.47 |
| 52 Week High | $65.00 | $28.74 |
| Indicator | ADM | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 42.87 | 80.47 |
| Support Level | $57.95 | $28.00 |
| Resistance Level | $61.17 | $26.96 |
| Average True Range (ATR) | 1.36 | 0.64 |
| MACD | -0.06 | 0.14 |
| Stochastic Oscillator | 29.54 | 89.88 |
Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.